Package leaflet: Information for the user Elaprase 2 mg ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform - Tolerable daily intake - Document - PDFSEARCH.IO

First Page		Document Content
Medicine Neurochemistry Clinical medicine RTT General anesthetics Dosage forms Calcium channel blockers Sodium channel blockers Ketamine Adverse effect Intravenous therapy FOLFOX		Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform Add to Reading List Source URL: www.medicines.org.uk Download Document from Source Website File Size: 89,06 KB Share Document on Facebook

	Médecins Neurosciences SFAR2016/MED-1209 La kétamine est-elle liée au stress post-traumatique ? Étude rétrospective d’une cohorte de 274 blessés de guerre. DocID: 1vnCI - View Document
	Microsoft Word - Joint Advisory Opinion by the BME BON and BOP regarding Ketamine Infusions at GHS November_2_ DocID: 1uVOF - View Document
	B-30 Kétamine G. Mion DocID: 1uI4S - View Document
	Funding anesthesia research to ensure pediatric safety Consensus Statement FAQs for Health Care Professionals Why was the Consensus Statement developed? In December 2012, SmartTots released its first Consensus Statement DocID: 1rnjb - View Document
	Intravenous infusion practice as a complex cognitive system: Exploring layers of Distributed Cognition Dominic Furniss 1 , Imogen Lyons 1 , Bryony DocID: 1rhqf - View Document